AHR and chronic kidney disease: Dou et al. demonstrated that CKD patients with stages 3–5 showed strong serum AHR-activating potential and upregulated mRNA levels of CYP1A1 and AHR repressor in whole blood compared to serum from healthy controls (Dou et al., 2018).